nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivermectin—ABCB1—peripheral nervous system neoplasm	0.27	1	CbGaD
Ivermectin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0577	0.0998	CbGbCtD
Ivermectin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0557	0.0964	CbGbCtD
Ivermectin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0418	0.0723	CbGbCtD
Ivermectin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0386	0.0668	CbGbCtD
Ivermectin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0356	0.0615	CbGbCtD
Ivermectin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0326	0.0563	CbGbCtD
Ivermectin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0263	0.0455	CbGbCtD
Ivermectin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0245	0.0424	CbGbCtD
Ivermectin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0241	0.0417	CbGbCtD
Ivermectin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0238	0.0411	CbGbCtD
Ivermectin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0222	0.0384	CbGbCtD
Ivermectin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0222	0.0384	CbGbCtD
Ivermectin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0218	0.0377	CbGbCtD
Ivermectin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0201	0.0347	CbGbCtD
Ivermectin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0201	0.0347	CbGbCtD
Ivermectin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0164	0.0284	CbGbCtD
Ivermectin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0149	0.0257	CbGbCtD
Ivermectin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0139	0.0241	CbGbCtD
Ivermectin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.012	0.0208	CbGbCtD
Ivermectin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0112	0.0194	CbGbCtD
Ivermectin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00858	0.0148	CbGbCtD
Ivermectin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.008	0.0138	CbGbCtD
Ivermectin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00786	0.0136	CbGbCtD
Ivermectin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00536	0.00927	CbGbCtD
Ivermectin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00514	0.00889	CbGbCtD
Ivermectin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00471	0.00814	CbGbCtD
Ivermectin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00321	0.00555	CbGbCtD
Ivermectin—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.000639	0.0663	CbGpPWpGaD
Ivermectin—NR1H4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000559	0.058	CbGpPWpGaD
Ivermectin—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000505	0.0524	CbGpPWpGaD
Ivermectin—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000428	0.0444	CbGpPWpGaD
Ivermectin—ABCC1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000423	0.0439	CbGpPWpGaD
Ivermectin—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000372	0.0386	CbGpPWpGaD
Ivermectin—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000367	0.0381	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000321	0.0333	CbGpPWpGaD
Ivermectin—NR1H4—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000314	0.0326	CbGpPWpGaD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000304	0.0315	CbGpPWpGaD
Ivermectin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000276	0.0286	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000194	0.0202	CbGpPWpGaD
Ivermectin—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000175	0.0181	CbGpPWpGaD
Ivermectin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000173	0.00122	CcSEcCtD
Ivermectin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000173	0.00121	CcSEcCtD
Ivermectin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000173	0.00121	CcSEcCtD
Ivermectin—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.00121	CcSEcCtD
Ivermectin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000173	0.00121	CcSEcCtD
Ivermectin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000173	0.00121	CcSEcCtD
Ivermectin—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000172	0.00121	CcSEcCtD
Ivermectin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000172	0.00121	CcSEcCtD
Ivermectin—Back pain—Etoposide—peripheral nervous system neoplasm	0.000171	0.0012	CcSEcCtD
Ivermectin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00017	0.0012	CcSEcCtD
Ivermectin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00017	0.0012	CcSEcCtD
Ivermectin—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00017	0.00119	CcSEcCtD
Ivermectin—GABRB3—Orphan transporters—COX2—peripheral nervous system neoplasm	0.00017	0.0176	CbGpPWpGaD
Ivermectin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.00118	CcSEcCtD
Ivermectin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000168	0.00118	CcSEcCtD
Ivermectin—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00118	CcSEcCtD
Ivermectin—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000167	0.00117	CcSEcCtD
Ivermectin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000167	0.00117	CcSEcCtD
Ivermectin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000167	0.00117	CcSEcCtD
Ivermectin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000167	0.0173	CbGpPWpGaD
Ivermectin—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000166	0.00117	CcSEcCtD
Ivermectin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.00116	CcSEcCtD
Ivermectin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000165	0.00116	CcSEcCtD
Ivermectin—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.00115	CcSEcCtD
Ivermectin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000164	0.00115	CcSEcCtD
Ivermectin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000164	0.00115	CcSEcCtD
Ivermectin—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000163	0.00115	CcSEcCtD
Ivermectin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000163	0.00114	CcSEcCtD
Ivermectin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000163	0.00114	CcSEcCtD
Ivermectin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000162	0.00114	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000162	0.00114	CcSEcCtD
Ivermectin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000161	0.00113	CcSEcCtD
Ivermectin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000161	0.00113	CcSEcCtD
Ivermectin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.00113	CcSEcCtD
Ivermectin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.00112	CcSEcCtD
Ivermectin—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00112	CcSEcCtD
Ivermectin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000159	0.00112	CcSEcCtD
Ivermectin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000159	0.0165	CbGpPWpGaD
Ivermectin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000158	0.00111	CcSEcCtD
Ivermectin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.00111	CcSEcCtD
Ivermectin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.00111	CcSEcCtD
Ivermectin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000158	0.00111	CcSEcCtD
Ivermectin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000158	0.00111	CcSEcCtD
Ivermectin—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000157	0.00111	CcSEcCtD
Ivermectin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000156	0.0011	CcSEcCtD
Ivermectin—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.00109	CcSEcCtD
Ivermectin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000155	0.00109	CcSEcCtD
Ivermectin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000155	0.00109	CcSEcCtD
Ivermectin—Rash—Topotecan—peripheral nervous system neoplasm	0.000155	0.00109	CcSEcCtD
Ivermectin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000155	0.00109	CcSEcCtD
Ivermectin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000155	0.00109	CcSEcCtD
Ivermectin—Cough—Etoposide—peripheral nervous system neoplasm	0.000154	0.00108	CcSEcCtD
Ivermectin—Headache—Topotecan—peripheral nervous system neoplasm	0.000154	0.00108	CcSEcCtD
Ivermectin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000154	0.00108	CcSEcCtD
Ivermectin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000154	0.00108	CcSEcCtD
Ivermectin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000154	0.00108	CcSEcCtD
Ivermectin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000154	0.00108	CcSEcCtD
Ivermectin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000154	0.00108	CcSEcCtD
Ivermectin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000154	0.00108	CcSEcCtD
Ivermectin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000153	0.00108	CcSEcCtD
Ivermectin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000153	0.00107	CcSEcCtD
Ivermectin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000153	0.00107	CcSEcCtD
Ivermectin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000153	0.00107	CcSEcCtD
Ivermectin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.00107	CcSEcCtD
Ivermectin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000152	0.00107	CcSEcCtD
Ivermectin—Pain—Vincristine—peripheral nervous system neoplasm	0.000152	0.00107	CcSEcCtD
Ivermectin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000152	0.00107	CcSEcCtD
Ivermectin—Rash—Melphalan—peripheral nervous system neoplasm	0.000152	0.00107	CcSEcCtD
Ivermectin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000152	0.00106	CcSEcCtD
Ivermectin—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000152	0.0157	CbGpPWpGaD
Ivermectin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.00106	CcSEcCtD
Ivermectin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00106	CcSEcCtD
Ivermectin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000151	0.00106	CcSEcCtD
Ivermectin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00106	CcSEcCtD
Ivermectin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00106	CcSEcCtD
Ivermectin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00015	0.00105	CcSEcCtD
Ivermectin—ABCC1—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.00015	0.0155	CbGpPWpGaD
Ivermectin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000149	0.00104	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00104	CcSEcCtD
Ivermectin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000147	0.00103	CcSEcCtD
Ivermectin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00103	CcSEcCtD
Ivermectin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000147	0.00103	CcSEcCtD
Ivermectin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.00103	CcSEcCtD
Ivermectin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000146	0.0152	CbGpPWpGaD
Ivermectin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.00103	CcSEcCtD
Ivermectin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.00103	CcSEcCtD
Ivermectin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000146	0.00103	CcSEcCtD
Ivermectin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000146	0.00102	CcSEcCtD
Ivermectin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000145	0.00102	CcSEcCtD
Ivermectin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000145	0.00102	CcSEcCtD
Ivermectin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000145	0.00102	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000143	0.00101	CcSEcCtD
Ivermectin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00101	CcSEcCtD
Ivermectin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.001	CcSEcCtD
Ivermectin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000143	0.001	CcSEcCtD
Ivermectin—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000999	CcSEcCtD
Ivermectin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000141	0.000989	CcSEcCtD
Ivermectin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000989	CcSEcCtD
Ivermectin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000141	0.000989	CcSEcCtD
Ivermectin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000141	0.000989	CcSEcCtD
Ivermectin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000986	CcSEcCtD
Ivermectin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00098	CcSEcCtD
Ivermectin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000139	0.000979	CcSEcCtD
Ivermectin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000976	CcSEcCtD
Ivermectin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000976	CcSEcCtD
Ivermectin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000138	0.000966	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000963	CcSEcCtD
Ivermectin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000961	CcSEcCtD
Ivermectin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000136	0.000958	CcSEcCtD
Ivermectin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.000956	CcSEcCtD
Ivermectin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000135	0.000947	CcSEcCtD
Ivermectin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000946	CcSEcCtD
Ivermectin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000931	CcSEcCtD
Ivermectin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00093	CcSEcCtD
Ivermectin—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000924	CcSEcCtD
Ivermectin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000131	0.000921	CcSEcCtD
Ivermectin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000918	CcSEcCtD
Ivermectin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000915	CcSEcCtD
Ivermectin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000911	CcSEcCtD
Ivermectin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000129	0.000903	CcSEcCtD
Ivermectin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000128	0.000901	CcSEcCtD
Ivermectin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000128	0.000897	CcSEcCtD
Ivermectin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000127	0.00089	CcSEcCtD
Ivermectin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.000888	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000883	CcSEcCtD
Ivermectin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000126	0.000883	CcSEcCtD
Ivermectin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000125	0.000881	CcSEcCtD
Ivermectin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000874	CcSEcCtD
Ivermectin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000124	0.000873	CcSEcCtD
Ivermectin—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000124	0.0129	CbGpPWpGaD
Ivermectin—Pain—Etoposide—peripheral nervous system neoplasm	0.000123	0.000866	CcSEcCtD
Ivermectin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000123	0.000866	CcSEcCtD
Ivermectin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000865	CcSEcCtD
Ivermectin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.000858	CcSEcCtD
Ivermectin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000122	0.000856	CcSEcCtD
Ivermectin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000849	CcSEcCtD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000121	0.0125	CbGpPWpGaD
Ivermectin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000119	0.000835	CcSEcCtD
Ivermectin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.000831	CcSEcCtD
Ivermectin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000118	0.000828	CcSEcCtD
Ivermectin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000118	0.000827	CcSEcCtD
Ivermectin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000825	CcSEcCtD
Ivermectin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000818	CcSEcCtD
Ivermectin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000818	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000817	CcSEcCtD
Ivermectin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000815	CcSEcCtD
Ivermectin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000813	CcSEcCtD
Ivermectin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000115	0.000805	CcSEcCtD
Ivermectin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000114	0.000801	CcSEcCtD
Ivermectin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000114	0.000801	CcSEcCtD
Ivermectin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000801	CcSEcCtD
Ivermectin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000799	CcSEcCtD
Ivermectin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000113	0.000795	CcSEcCtD
Ivermectin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000793	CcSEcCtD
Ivermectin—Rash—Vincristine—peripheral nervous system neoplasm	0.000112	0.000788	CcSEcCtD
Ivermectin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000112	0.000788	CcSEcCtD
Ivermectin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000787	CcSEcCtD
Ivermectin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000785	CcSEcCtD
Ivermectin—Headache—Vincristine—peripheral nervous system neoplasm	0.000112	0.000783	CcSEcCtD
Ivermectin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000771	CcSEcCtD
Ivermectin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000757	CcSEcCtD
Ivermectin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000756	CcSEcCtD
Ivermectin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000106	0.000746	CcSEcCtD
Ivermectin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000106	0.000743	CcSEcCtD
Ivermectin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00074	CcSEcCtD
Ivermectin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000729	CcSEcCtD
Ivermectin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000104	0.000727	CcSEcCtD
Ivermectin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000103	0.0107	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000103	0.0107	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000103	0.0107	CbGpPWpGaD
Ivermectin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000717	CcSEcCtD
Ivermectin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000102	0.000717	CcSEcCtD
Ivermectin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000703	CcSEcCtD
Ivermectin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.000699	CcSEcCtD
Ivermectin—Rash—Cisplatin—peripheral nervous system neoplasm	9.93e-05	0.000697	CcSEcCtD
Ivermectin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.92e-05	0.000697	CcSEcCtD
Ivermectin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.87e-05	0.000693	CcSEcCtD
Ivermectin—Back pain—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000673	CcSEcCtD
Ivermectin—Dizziness—Etoposide—peripheral nervous system neoplasm	9.54e-05	0.00067	CcSEcCtD
Ivermectin—Chills—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000664	CcSEcCtD
Ivermectin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	9.36e-05	0.00971	CbGpPWpGaD
Ivermectin—Nausea—Cisplatin—peripheral nervous system neoplasm	9.36e-05	0.000657	CcSEcCtD
Ivermectin—Vomiting—Etoposide—peripheral nervous system neoplasm	9.17e-05	0.000644	CcSEcCtD
Ivermectin—Anaemia—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000643	CcSEcCtD
Ivermectin—Rash—Etoposide—peripheral nervous system neoplasm	9.1e-05	0.000639	CcSEcCtD
Ivermectin—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.09e-05	0.000638	CcSEcCtD
Ivermectin—Headache—Etoposide—peripheral nervous system neoplasm	9.04e-05	0.000635	CcSEcCtD
Ivermectin—Vertigo—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000625	CcSEcCtD
Ivermectin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000623	CcSEcCtD
Ivermectin—Back pain—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000623	CcSEcCtD
Ivermectin—GABRB3—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	8.75e-05	0.00907	CbGpPWpGaD
Ivermectin—Cough—Epirubicin—peripheral nervous system neoplasm	8.65e-05	0.000607	CcSEcCtD
Ivermectin—Convulsion—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000603	CcSEcCtD
Ivermectin—Nausea—Etoposide—peripheral nervous system neoplasm	8.57e-05	0.000602	CcSEcCtD
Ivermectin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000595	CcSEcCtD
Ivermectin—Myalgia—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000592	CcSEcCtD
Ivermectin—Chest pain—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000592	CcSEcCtD
Ivermectin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000592	CcSEcCtD
Ivermectin—Discomfort—Epirubicin—peripheral nervous system neoplasm	8.34e-05	0.000585	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.27e-05	0.00858	CbGpPWpGaD
Ivermectin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000578	CcSEcCtD
Ivermectin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000576	CcSEcCtD
Ivermectin—Confusional state—Epirubicin—peripheral nervous system neoplasm	8.16e-05	0.000573	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.12e-05	0.00842	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	8.11e-05	0.00842	CbGpPWpGaD
Ivermectin—Oedema—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000568	CcSEcCtD
Ivermectin—Cough—Doxorubicin—peripheral nervous system neoplasm	8e-05	0.000562	CcSEcCtD
Ivermectin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	8e-05	0.0083	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.97e-05	0.00827	CbGpPWpGaD
Ivermectin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000558	CcSEcCtD
Ivermectin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000554	CcSEcCtD
Ivermectin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000549	CcSEcCtD
Ivermectin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000548	CcSEcCtD
Ivermectin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000548	CcSEcCtD
Ivermectin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000548	CcSEcCtD
Ivermectin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000542	CcSEcCtD
Ivermectin—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000541	CcSEcCtD
Ivermectin—NR1H4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.67e-05	0.00795	CbGpPWpGaD
Ivermectin—Hypotension—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000531	CcSEcCtD
Ivermectin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.55e-05	0.00053	CcSEcCtD
Ivermectin—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.48e-05	0.000525	CcSEcCtD
Ivermectin—GABRB3—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	7.44e-05	0.00771	CbGpPWpGaD
Ivermectin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000517	CcSEcCtD
Ivermectin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.000513	CcSEcCtD
Ivermectin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000508	CcSEcCtD
Ivermectin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000506	CcSEcCtD
Ivermectin—Somnolence—Epirubicin—peripheral nervous system neoplasm	7.19e-05	0.000505	CcSEcCtD
Ivermectin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000501	CcSEcCtD
Ivermectin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000494	CcSEcCtD
Ivermectin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000491	CcSEcCtD
Ivermectin—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.00049	CcSEcCtD
Ivermectin—NR1H4—Gene Expression—EED—peripheral nervous system neoplasm	6.92e-05	0.00718	CbGpPWpGaD
Ivermectin—Constipation—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000486	CcSEcCtD
Ivermectin—Pain—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000486	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000479	CcSEcCtD
Ivermectin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000468	CcSEcCtD
Ivermectin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000468	CcSEcCtD
Ivermectin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.65e-05	0.000467	CcSEcCtD
Ivermectin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000464	CcSEcCtD
Ivermectin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000457	CcSEcCtD
Ivermectin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000453	CcSEcCtD
Ivermectin—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000451	CcSEcCtD
Ivermectin—Pain—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000449	CcSEcCtD
Ivermectin—Constipation—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000449	CcSEcCtD
Ivermectin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000449	CcSEcCtD
Ivermectin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000449	CcSEcCtD
Ivermectin—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	6.26e-05	0.00649	CbGpPWpGaD
Ivermectin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000433	CcSEcCtD
Ivermectin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.00043	CcSEcCtD
Ivermectin—GABRB3—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	6.06e-05	0.00629	CbGpPWpGaD
Ivermectin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000418	CcSEcCtD
Ivermectin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000417	CcSEcCtD
Ivermectin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000415	CcSEcCtD
Ivermectin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000415	CcSEcCtD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.9e-05	0.00612	CbGpPWpGaD
Ivermectin—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000407	CcSEcCtD
Ivermectin—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000402	CcSEcCtD
Ivermectin—GABRB3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	5.57e-05	0.00578	CbGpPWpGaD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	5.56e-05	0.00576	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	5.55e-05	0.00576	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—SUZ12—peripheral nervous system neoplasm	5.54e-05	0.00574	CbGpPWpGaD
Ivermectin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.000389	CcSEcCtD
Ivermectin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000387	CcSEcCtD
Ivermectin—NR1H4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.38e-05	0.00558	CbGpPWpGaD
Ivermectin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000377	CcSEcCtD
Ivermectin—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000376	CcSEcCtD
Ivermectin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.000372	CcSEcCtD
Ivermectin—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.14e-05	0.000361	CcSEcCtD
Ivermectin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000359	CcSEcCtD
Ivermectin—Rash—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000358	CcSEcCtD
Ivermectin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.09e-05	0.000358	CcSEcCtD
Ivermectin—Headache—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000356	CcSEcCtD
Ivermectin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000347	CcSEcCtD
Ivermectin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.82e-05	0.005	CbGpPWpGaD
Ivermectin—Nausea—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000337	CcSEcCtD
Ivermectin—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	4.8e-05	0.00498	CbGpPWpGaD
Ivermectin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000334	CcSEcCtD
Ivermectin—Rash—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000331	CcSEcCtD
Ivermectin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000331	CcSEcCtD
Ivermectin—Headache—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000329	CcSEcCtD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	4.66e-05	0.00484	CbGpPWpGaD
Ivermectin—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	4.6e-05	0.00477	CbGpPWpGaD
Ivermectin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	4.59e-05	0.00477	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.47e-05	0.00464	CbGpPWpGaD
Ivermectin—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000312	CcSEcCtD
Ivermectin—GABRB3—Neuronal System—BCHE—peripheral nervous system neoplasm	4.27e-05	0.00443	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.14e-05	0.00429	CbGpPWpGaD
Ivermectin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.08e-05	0.00424	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.06e-05	0.00421	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.89e-05	0.00404	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GNS—peripheral nervous system neoplasm	3.89e-05	0.00404	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	3.87e-05	0.00401	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.79e-05	0.00393	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.75e-05	0.00388	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—NME1—peripheral nervous system neoplasm	3.73e-05	0.00387	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—COX2—peripheral nervous system neoplasm	3.59e-05	0.00373	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.42e-05	0.00355	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.3e-05	0.00342	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.27e-05	0.00339	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.2e-05	0.00332	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	2.77e-05	0.00288	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.63e-05	0.00273	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—ENO2—peripheral nervous system neoplasm	2.36e-05	0.00245	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.31e-05	0.0024	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.28e-05	0.00237	CbGpPWpGaD
Ivermectin—ABCC1—Disease—GNS—peripheral nervous system neoplasm	2.27e-05	0.00235	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.23e-05	0.00232	CbGpPWpGaD
Ivermectin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.21e-05	0.00229	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.19e-05	0.00227	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.18e-05	0.00227	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.08e-05	0.00216	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.01e-05	0.00208	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—BCHE—peripheral nervous system neoplasm	1.99e-05	0.00207	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.98e-05	0.00206	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.93e-05	0.002	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.91e-05	0.00198	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	1.9e-05	0.00197	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.9e-05	0.00197	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—TH—peripheral nervous system neoplasm	1.87e-05	0.00194	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.85e-05	0.00192	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	1.82e-05	0.00189	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.78e-05	0.00185	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.76e-05	0.00183	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	1.75e-05	0.00182	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.74e-05	0.00181	CbGpPWpGaD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	1.74e-05	0.0018	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.73e-05	0.00179	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	1.7e-05	0.00176	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.67e-05	0.00173	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.61e-05	0.00167	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.6e-05	0.00166	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.59e-05	0.00165	CbGpPWpGaD
Ivermectin—NR1H4—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.59e-05	0.00165	CbGpPWpGaD
Ivermectin—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	1.59e-05	0.00165	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.58e-05	0.00164	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.56e-05	0.00162	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.54e-05	0.0016	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GNAS—peripheral nervous system neoplasm	1.53e-05	0.00159	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	1.5e-05	0.00156	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.5e-05	0.00156	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.4e-05	0.00146	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.38e-05	0.00143	CbGpPWpGaD
Ivermectin—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	1.38e-05	0.00143	CbGpPWpGaD
Ivermectin—GABRB3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.31e-05	0.00136	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.25e-05	0.0013	CbGpPWpGaD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.21e-05	0.00125	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.15e-05	0.00119	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.14e-05	0.00118	CbGpPWpGaD
Ivermectin—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.11e-05	0.00115	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.05e-05	0.00109	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.01e-05	0.00105	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—HRAS—peripheral nervous system neoplasm	1e-05	0.00104	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	9.73e-06	0.00101	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.53e-06	0.000988	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.43e-06	0.000978	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.28e-06	0.000963	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	9.15e-06	0.000949	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	9.04e-06	0.000938	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	8.67e-06	0.000899	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	8.56e-06	0.000888	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	8.35e-06	0.000866	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.17e-06	0.000847	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	8.05e-06	0.000835	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.71e-06	0.000799	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—MYC—peripheral nervous system neoplasm	7.66e-06	0.000794	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.59e-06	0.000787	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	7.47e-06	0.000775	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.44e-06	0.000771	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.33e-06	0.00076	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	6.57e-06	0.000682	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.45e-06	0.000669	CbGpPWpGaD
Ivermectin—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	6.2e-06	0.000643	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.11e-06	0.000633	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	5.57e-06	0.000578	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	5.48e-06	0.000568	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	5.34e-06	0.000554	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—AKT1—peripheral nervous system neoplasm	5.31e-06	0.000551	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.16e-06	0.000535	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	5.14e-06	0.000533	CbGpPWpGaD
Ivermectin—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	4.9e-06	0.000508	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	4.63e-06	0.00048	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.42e-06	0.000458	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	4.35e-06	0.000451	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—AKT1—peripheral nervous system neoplasm	4.13e-06	0.000428	CbGpPWpGaD
Ivermectin—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	3.73e-06	0.000387	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.55e-06	0.000369	CbGpPWpGaD
Ivermectin—ABCC1—Disease—MYC—peripheral nervous system neoplasm	3.47e-06	0.00036	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.38e-06	0.00035	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.85e-06	0.000296	CbGpPWpGaD
Ivermectin—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	2.73e-06	0.000283	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.72e-06	0.000282	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.68e-06	0.000278	CbGpPWpGaD
Ivermectin—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	2.41e-06	0.00025	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.19e-06	0.000227	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.15e-06	0.000223	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	2.02e-06	0.000209	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.77e-06	0.000184	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	9.59e-07	9.95e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.91e-07	6.13e-05	CbGpPWpGaD
